List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 564 studies with search of: "Attention Deficit-Hyperactivity Disorder"
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Efficacy & Safety of KAPVAY™ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: KAPVAY™ (clonidine hydrochloride);   Drug: Placebo
2 Completed Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity;   Attention Deficit Hyperactivity Disorders
Intervention: Drug: NRP104
3 Completed An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Drug: methylphenidate hydrochloride
4 Completed
Has Results 		A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Atomoxetine Hydrochloride;   Drug: Placebo
5 Completed
Has Results 		An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity;   Attention Deficit Hyperactivity Disorders
Intervention: Drug: Vyvanse (lisdexamfetamine dimesylate), NRP104
6 Completed Pilot Study of Duloxetine in Adult Attention Deficit Hyperactivity Disorder(ADHD)
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: duloxetine;   Drug: placebo
7 Completed
Has Results 		Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)
Conditions: Attention Deficit Hyperactivity Disorder;   Reading Disorder
Interventions: Drug: Atomoxetine Hydrochloride;   Drug: placebo
8 Terminated
Has Results 		Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE
Conditions: Attention Deficit Hyperactivity Disorder;   Cannabis Abuse
Intervention: Drug: Atomoxetine
9 Completed
Has Results 		A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Atomoxetine
10 Active, not recruiting A Pilot Trial of Homeopathic Treatment for Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Other: Homeopathic Remedies
11 Completed
Has Results 		Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Atomoxetine Hydrochloride;   Drug: Atomoxetine hydrochloride
12 Completed A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity
Intervention: Drug: JNJ-31001074
13 Completed A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity
Intervention: Drug: JNJ-31001074
14 Completed A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: methylphenidate hydrochloride extended-release tablets
15 Completed Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: CLONICEL (Clonidine HCl sustained release)
16 Active, not recruiting Influence of Education on Acceptance of Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Among Women
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Behavioral: Education
17 Completed A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity
Interventions: Drug: Atomoxetine 80 mg/d;   Drug: Placebo;   Drug: OROS methylphenidate HCl 54 mg/d;   Drug: JNJ-31001074 3 mg/d;   Drug: JNJ-31001074 1 mg/d;   Drug: JNJ-31001074 10 mg/d
18 Recruiting Pharmacogenetic Studies on Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention:
19 Completed A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: LY2216684;   Drug: Methylphenidate;   Drug: Placebo (tablet);   Drug: Placebo (capsule)
20 Unknown † Breathing Meditation With Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Behavioral: Breathing Meditation

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services